Using RNAi to Identify & Validate Novel Targets for Cancer Drug Development
Time: 11:30 am
day: Conference Day One
Details:
• RNAi knockdown is a key step in determining the best modality for drug development
• Selected Oncology targets may not require complete knockdown!
• Explore examples from the Histone methyltransferase family
